Institute of Biomedical Research and Innovation Hospital
Kobe, Hyōgo 650-0047
0 studies enrolling now · 1 studies all time
What they study most
First Line Non-Small Cell Lung Cancer
Studies at this site
- Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed